EVP, Research & CSO of Vir Biotechnology, Inc. (NYSE:VIR), Virgin Herbert, sells 2,340 shares worth $63,848
According to Vir Biotechnology, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 05:00 PM, company EVP, Research & CSO, Virgin Herbert disclosed selling 2,340 shares at a cost of $27.29. At the time of this transaction (Nov 24), this trade was worth $63,848 in total. As of Nov 24, Virgin Herbert now owns 23,700 shares in total worth about $673,317.0.
For the last few recent trades made by Vir Biotechnology, Inc. (NYSE:VIR) EVP, Research & CSO, Virgin Herbert, we have the following information:
- SEC Form 4 filing: Oct 27: Sold 3,805 shares at the rate of $35.04 per share. Total worth of this trade was $133,335. Total number of shares owned as of Oct 27 were 23,700
- SEC Form 4 filing: Oct 13: Sold 5,560 shares at the rate of $43.03 per share. Total worth of this trade was $239,236. Total number of shares owned as of Oct 13 were 23,700
- SEC Form 4 filing: Sep 29: Sold 3,510 shares at the rate of $38.00 per share. Total worth of this trade was $133,380. Total number of shares owned as of Sep 29 were 23,700
Posted by
George Daniels
on Wednesday November 25 2020, 6:36 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
